12:00 AM
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Quillivant XR methylphenidate regulatory update

NextWave said FDA approved Quillivant XR methylphenidate to treat ADHD. NextWave said the drug will be available in January. Quillivant...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >